The coming week shows a busy reporting schedule for international stocks. Among those, six of IBD's Top 10 World Stocks are scheduled to deliver results.
Dublin, Ireland-based drugmaker Mallinckrodt (NYSE:
The consensus for Mallinckrodt's EPS is an increase of 52% for the quarter, underscored by a 51% sales gain. The stock pegged a high in March, after

Fiscal Q3 results should give some sense of progress on the combination.
The...